COVID-19 pandemic
The Russian Direct Investment Fund files the registration of the Sputnik V vaccine with the European Medicines Agency with the first review expected in February.
Sources: The Moscow Times
Changes
- Russian Direct Investment Fund (RDIF) files the registration of Sputnik V vaccine with the European Medicines Agency with the first review is expected in February.
- The Russian Direct Investment Fund files the registration of the Sputnik V vaccine with the European Medicines Agency with the first review expected in February.